Showing 6 posts of 381 posts found.

New diabetes drug launched in UK

March 14, 2007
Sales and Marketing Byetta, diabetes

A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

Byetta receives EU approval for Type II diabetes

November 28, 2006
Sales and Marketing diabetes

Lilly and Amylin's new diabetes treatment, Byetta, has won EU approval.It is the first in a new class of anti-diabetic …

Surprise delay for Novartis’ Galvus

November 15, 2006
Sales and Marketing Galvus, diabetes

The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …

New diabetes drug Byetta set for European approval

September 22, 2006
Sales and Marketing Byetta, diabetes

Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …

Pfizer to go it alone with Exubera

January 16, 2006
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …

Latest content